Randomized Trial Comparing Two Sirolimus-Eluting Stents in Diabetes Mellitus

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 860 participants.

Also called NCT04660240

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 860 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04660240
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Mexico (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04660240. Randomized; single masking; primary purpose treatment. Start 2020-10-01 (actual); primary completion 2025-05-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Randomized Trial Comparing Two Sirolimus-Eluting Stents in Diabetes Mellitus
Acronym
INC-DM
Condition
Diabetes Mellitus
Condition
Acute Coronary Syndrome
Intervention (Device)
Abluminus Sirolimus Eluting Stent System (ASES)
Intervention (Device)
Orsiro Sirolimus Eluting Coronary Stent System (OSES)
Lead sponsor
Instituto Nacional de Cardiologia Ignacio Chavez (class: other)

Record details

Record id
cardio:ct-nct04660240
Content hash
3b731aa2fd6a6f91ff826e99b9b5ffa525ec1d8e5d8c41dab669a59bf9560cb7